Expression of Therapeutic Gene FCU1 Sensitizes Pancreatic Cancer Cells to 5-Fluorocytosine and Enhances the Cytotoxic Effect of 5-Fluorouracil
- Authors: Kopantsev E.P.1, Kostina M.B.1, Grankina E.V.2, Kopantseva M.R.1, Egorov V.I.3, Sverdlov E.D.1
- 
							Affiliations: 
							- Laboratory of Structure and Functions of Human Genes, M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- A. V. Vishnevsky Institute of Surgery, Ministry of the Health of the Russian Federation
- Municipal Clinical Hospital No. 5, Moscow City Health Department
 
- Issue: Vol 161, No 6 (2016)
- Pages: 808-810
- Section: Genetics
- URL: https://journals.rcsi.science/0007-4888/article/view/237803
- DOI: https://doi.org/10.1007/s10517-016-3517-9
- ID: 237803
Cite item
Abstract
Hybrid therapeutic gene FCU1 gene was cloned into a lentiviral expression vector and the therapeutic effect of its expression was studied in three pancreatic cancer cell lines. Expression of FCU1 gene sensitized cells of two of three studied pancreatic cancer cell lines to 5-fluorocytosine. In addition, uracil phosphoribosyl transferase activity of the hybrid FCU1 protein increased sensitivity of transfected cells of all three studied pancreatic cancer cell lines to 5-fluorouracil, a standard chemotherapeutic agent.
About the authors
E. P. Kopantsev
Laboratory of Structure and Functions of Human Genes, M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
							Author for correspondence.
							Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
M. B. Kostina
Laboratory of Structure and Functions of Human Genes, M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
E. V. Grankina
A. V. Vishnevsky Institute of Surgery, Ministry of the Health of the Russian Federation
														Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
M. R. Kopantseva
Laboratory of Structure and Functions of Human Genes, M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
V. I. Egorov
Municipal Clinical Hospital No. 5, Moscow City Health Department
														Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
E. D. Sverdlov
Laboratory of Structure and Functions of Human Genes, M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
														Email: kopantzev@ibch.ru
				                					                																			                												                	Russian Federation, 							Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					